GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (LTS:0REN) » Definitions » Cyclically Adjusted PB Ratio

Edwards Lifesciences (LTS:0REN) Cyclically Adjusted PB Ratio : 12.84 (As of Jun. 04, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Edwards Lifesciences Cyclically Adjusted PB Ratio?

As of today (2024-06-04), Edwards Lifesciences's current share price is CHF77.55964. Edwards Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was CHF6.04. Edwards Lifesciences's Cyclically Adjusted PB Ratio for today is 12.84.

The historical rank and industry rank for Edwards Lifesciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

LTS:0REN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.44   Med: 14.75   Max: 26.56
Current: 11.8

During the past years, Edwards Lifesciences's highest Cyclically Adjusted PB Ratio was 26.56. The lowest was 6.44. And the median was 14.75.

LTS:0REN's Cyclically Adjusted PB Ratio is ranked worse than
93.04% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.095 vs LTS:0REN: 11.80

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Edwards Lifesciences's adjusted book value per share data for the three months ended in Mar. 2024 was CHF10.500. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is CHF6.04 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Edwards Lifesciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Edwards Lifesciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Cyclically Adjusted PB Ratio Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.18 21.83 25.42 12.18 10.75

Edwards Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.93 14.18 10.02 10.75 12.84

Competitive Comparison of Edwards Lifesciences's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted PB Ratio falls into.



Edwards Lifesciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Edwards Lifesciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=77.55964/6.04
=12.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Edwards Lifesciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.5/131.7762*131.7762
=10.500

Current CPI (Mar. 2024) = 131.7762.

Edwards Lifesciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.697 100.560 3.534
201409 2.985 100.428 3.917
201412 3.304 99.070 4.395
201503 3.363 99.621 4.448
201506 3.310 100.684 4.332
201509 3.644 100.392 4.783
201512 3.855 99.792 5.091
201603 3.549 100.470 4.655
201606 3.755 101.688 4.866
201609 4.086 101.861 5.286
201612 4.206 101.863 5.441
201703 4.352 102.862 5.575
201706 4.494 103.349 5.730
201709 4.795 104.136 6.068
201712 4.638 104.011 5.876
201803 4.868 105.290 6.093
201806 4.991 106.317 6.186
201809 5.189 106.507 6.420
201812 4.999 105.998 6.215
201903 5.517 107.251 6.779
201906 5.545 108.070 6.761
201909 6.041 108.329 7.349
201912 6.498 108.420 7.898
202003 6.041 108.902 7.310
202006 5.877 108.767 7.120
202009 6.184 109.815 7.421
202012 6.509 109.897 7.805
202103 6.966 111.754 8.214
202106 7.479 114.631 8.598
202109 8.192 115.734 9.327
202112 8.612 117.630 9.648
202203 8.742 121.301 9.497
202206 9.304 125.017 9.807
202209 9.770 125.227 10.281
202212 8.893 125.222 9.358
202303 9.130 127.348 9.447
202306 9.443 128.729 9.667
202309 9.875 129.860 10.021
202312 9.567 129.419 9.741
202403 10.500 131.776 10.500

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Edwards Lifesciences  (LTS:0REN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Edwards Lifesciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (LTS:0REN) Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (LTS:0REN) Headlines

No Headlines